Correlation Between Amylyx Pharmaceuticals and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and MAIA Biotechnology, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and MAIA Biotechnology.
Diversification Opportunities for Amylyx Pharmaceuticals and MAIA Biotechnology
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Amylyx and MAIA is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and MAIA Biotechnology
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the MAIA Biotechnology. But the etf apears to be less risky and, when comparing its historical volatility, Amylyx Pharmaceuticals is 1.33 times less risky than MAIA Biotechnology. The etf trades about -0.12 of its potential returns per unit of risk. The MAIA Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 199.00 in MAIA Biotechnology on October 25, 2024 and sell it today you would lose (4.00) from holding MAIA Biotechnology or give up 2.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. MAIA Biotechnology
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| MAIA Biotechnology |
Amylyx Pharmaceuticals and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and MAIA Biotechnology
The main advantage of trading using opposite Amylyx Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |